No. |
Gene |
UniProt ID |
Protein Name |
Pathway |
PDB |
Confidence score |
1 |
PDE4B |
Q07343 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B |
hsa00230; hsa04024; hsa04928; hsa05032 |
|
44.5%
|
2 |
PDE4A |
P27815 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A |
hsa00230; hsa04024; hsa04928; hsa05032 |
2QYK; 3I8V; 3TVX |
35.5%
|
3 |
PDE4C |
Q08493 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C |
hsa00230; hsa04024; hsa04928; hsa05032 |
1LXU; 2QYM |
28.0%
|
4 |
ADRA1A |
P35348 |
Alpha-1A adrenergic receptor |
hsa04020; hsa04022; hsa04080; hsa04152; hsa04261; hsa04270; hsa04970 |
NA |
15.5%
|
5 |
PTGDR2 |
Q9Y5Y4 |
Prostaglandin D2 receptor 2 |
NA |
NA |
15.4%
|
6 |
HINT1 |
P49773 |
Histidine triad nucleotide-binding protein 1 |
NA |
1AV5; 1KPA; 1KPB; 1KPC; 1KPE; 1KPF; 3TW2; 4EQE; 4EQG; 4EQH |
15.3%
|
7 |
ADA |
P00813 |
Adenosine deaminase |
hsa00230; hsa01100; hsa05340 |
1M7M; 3IAR |
15.2%
|
8 |
ADORA1 |
P30542 |
Adenosine receptor A1 |
hsa04022; hsa04024; hsa04071; hsa04080; hsa04923; hsa04924; hsa05032 |
NA |
15.1%
|
9 |
PDE7B |
Q9NP56 |
cAMP-specific 3',5'-cyclic phosphodiesterase 7B |
hsa00230; hsa05032 |
1LXW |
13.7%
|
10 |
PDE2A |
O00408 |
cGMP-dependent 3',5'-cyclic phosphodiesterase |
hsa00230; hsa04022; hsa04740; hsa04925; hsa05032 |
1Z1L; 3IBJ; 3ITM; 3ITU; 4C1I; 4D08; 4D09; 4HTX; 4HTZ; 4JIB |
13.5%
|
11 |
MAP2K1 |
Q02750 |
Dual specificity mitogen-activated protein kinase kinase 1 |
hsa01521; hsa01522; hsa04010; hsa04012; hsa04014; hsa04015; hsa04022; hsa04024; hsa04062; hsa04066; hsa04068; hsa04071; hsa04072; hsa04114; hsa04140; hsa04150; hsa04151; hsa04210; hsa04218; hsa04270; hsa04370; hsa04371; hsa04380; hsa04510; hsa04540; hsa04550; hsa04620; hsa04650; hsa04660; hsa04662; hsa04664; hsa04666; hsa04668; hsa04720; hsa04722; hsa04725; hsa04726; hsa04730; hsa04810; hsa04910; hsa04912; hsa04914; hsa04915; hsa04916; hsa04917; hsa04919; hsa04921; hsa04926; hsa04928; hsa04934; hsa05020; hsa05034; hsa05161; hsa05163; hsa05164; hsa05165; hsa05167; hsa05170; hsa05200; hsa05205; hsa05206; hsa05210; hsa05211; hsa05212; hsa05213; hsa05214; hsa05215; hsa05216; hsa05218; hsa05219; hsa05220; hsa05221; hsa05223; hsa05224; hsa05225; hsa05226; hsa05230; hsa05231 |
|
13.3%
|
12 |
PDE7A |
Q13946 |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A |
hsa00230; hsa05032 |
1ZKL; 3G3N; 4PM0; 4Y2B |
13.2%
|
13 |
PYGL |
P06737 |
Glycogen phosphorylase, liver form |
hsa00500; hsa01100; hsa04217; hsa04910; hsa04922; hsa04931 |
1EM6; 1EXV; 1FA9; 1FC0; 1L5Q; 1L5R; 1L5S; 1L7X; 1XOI; 2ATI; 2QLL; 2ZB2; 3CEH; 3CEJ; 3CEM; 3DD1; 3DDS; 3DDW |
13.1%
|
14 |
PKIA |
P61925 |
cAMP-dependent protein kinase inhibitor alpha |
hsa05034 |
|
13.1%
|
15 |
ADRA1B |
P35368 |
Alpha-1B adrenergic receptor |
hsa04020; hsa04022; hsa04080; hsa04261; hsa04270; hsa04970 |
NA |
12.9%
|
16 |
PDE10A |
Q9Y233 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A |
hsa00230; hsa05032 |
|
12.7%
|
17 |
PDE8A |
O60658 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A |
hsa00230; hsa04927; hsa04934; hsa05032 |
1LHQ; 1LXX; 3ECM; 3ECN |
12.6%
|
18 |
DHODH |
Q02127 |
Dihydroorotate dehydrogenase (quinone), mitochondrial |
hsa00240; hsa01100 |
|
12.4%
|
19 |
CHEK1 |
O14757 |
Serine/threonine-protein kinase Chk1 |
hsa04110; hsa04115; hsa04218; hsa05166; hsa05170; hsa05203 |
|
12.1%
|
20 |
ADRB1 |
P08588 |
Beta-1 adrenergic receptor |
hsa04020; hsa04022; hsa04024; hsa04080; hsa04261; hsa04540; hsa04923; hsa04924; hsa04970; hsa05414 |
2LSQ |
12.1%
|